Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.58 |
| ▸ | BLM | P54132 | 3/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.58 |
| ▸ | GMNN | O75496 | 2/20 | 0.58 |
| ▸ | USP2 | O75604 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.58 |
| ▸ | APEX1 | P27695 | 2/20 | 0.58 |
| ▸ | RECQL | P46063 | 2/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | TERT | O14746 | 3/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | PPARG | P37231 | 3/20 | 0.50 |
| ▸ | PPARD | Q03181 | 3/20 | 0.50 |
| ▸ | PPARA | Q07869 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14322640 | 1.00 | CYP1A2 (0.58) | CYP1A2CYP2C19BLMHSD17B10GMNN | |
| SCHEMBL600896 | 1.00 | CYP1A2 (0.58) | CYP1A2CYP2C19BLMHSD17B10GMNN | |
| SCHEMBL20680343 | 0.98 | CYP1A2 (0.56) | CYP1A2CYP2C19BLMHSD17B10GMNN | |
| SCHEMBL19357333 | 0.98 | CYP1A2 (0.56) | CYP1A2CYP2C19BLMHSD17B10GMNN | |
| SCHEMBL16401654 | 0.93 | CYP2C19 (0.49) | CYP1A2CYP2C19BLMHSD17B10GMNN | |
| SCHEMBL16401332 | 0.93 | CYP2C19 (0.49) | CYP1A2CYP2C19BLMHSD17B10GMNN | |
| SCHEMBL16401330 | 0.93 | CYP2C19 (0.49) | CYP1A2CYP2C19BLMHSD17B10GMNN | |
| SCHEMBL23534464 | 0.85 | CYP2C19 (0.43) | CYP1A2CYP2C19BLMHSD17B10GMNN | |
| SCHEMBL366778 | 0.85 | CYP2C19 (0.43) | CYP1A2CYP2C19BLMHSD17B10GMNN | |
| SCHEMBL366777 | 0.85 | CYP2C19 (0.43) | CYP1A2CYP2C19BLMHSD17B10GMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720088-A1 | CONSTRAINED PEPTIDE INHIBITORS OF LRRK2-FADD INTERACTIONS | University of Georgia Research Foundation, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4713348-A1 | DOUBLY CONSTRAINED PEPTIDES AS ALLOSTERIC INHIBITORS OF LEUCINE RICH REPEAT KINASE 2 | University of Georgia Research Foundation, Inc. (US) | 2026-03-25 | — | — | EP | claimed |
| WO-2025245225-A1 | STAPLED PEPTIDE PROTEOLYSIS TARGETING CHIMERAS (SP-PROTACS) AND METHODS OF USE | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| US-12391733-B2 | Stapled intracellular-targeting antimicrobial peptides to treat infection | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2025-08-19 | — | — | US | claimed |
| WO-2025085624-A1 | INHIBITORS OF RAB-RILPL INTERACTIONS AND USES THEREOF | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2025-04-24 | — | — | WO | claimed |
| EP-3986438-B1 | P53 ACTIVATOR PEPTIDOMIMETIC MACROCYCLES | MERCK SHARP & DOHME LLC (US) | 2025-04-16 | — | — | EP | claimed |
| US-12264185-B2 | Stabilized BCL9 peptides for treatment of aberrant Wnt signaling | WNTRX PHARMACEUTICALS INC. (US) | 2025-04-01 | — | — | US | claimed |
| WO-2024243509-A1 | CONSTRAINED PEPTIDE INHIBITORS OF LRRK2-FADD INTERACTIONS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2024-11-28 | — | — | WO | claimed |
| EP-4467153-A1 | CONSTRAINED PEPTIDE INHIBITORS OF LRRK2-FADD INTERACTIONS | University of Georgia Research Foundation, Inc. (US) | 2024-11-27 | — | — | EP | claimed |
| WO-2024238623-A1 | DOUBLY CONSTRAINED PEPTIDES AS ALLOSTERIC INHIBITORS OF LEUCINE RICH REPEAT KINASE 2 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2024-11-21 | — | — | WO | claimed |
| US-20150291682-A1 | MIMETIC PEPTIDES | LES HOPITAUX UNIVERSITAIRES DE GENEVE (CH) | 2015-10-15 | — | — | US | claimed |
| EP-2917234-A1 | MIMETIC PEPTIDES | Les Hôpitaux Universitaires de Genève (CH) | 2015-09-16 | — | — | EP | claimed |
| US-8940864-B2 | Stabilized therapeutic small helical antiviral peptides | NEW YORK BLOOD CENTER, INC. (US) | 2015-01-27 | — | — | US | claimed |
| US-8933019-B2 | Antiviral cell-penetrating peptides | NEW YORK BLOOD CENTER, INC. (US) | 2015-01-13 | — | — | US | claimed |
| WO-2014072916-A1 | MIMETIC PEPTIDES | LES HOPITAUX UNIVERSITAIRES DE GENEVE (CH) | 2014-05-15 | — | — | WO | claimed |
| US-20130059776-A1 | Antiviral Cell-Penetrating Peptides | NEW YORK BLOOD CENTER | 2013-03-07 | — | — | US | claimed |
| US-8324153-B2 | Antiviral cell-penetrating peptides | NEW YORK BLOOD CENTER, INC. (US) | 2012-12-04 | — | — | US | claimed |
| EP-2283033-A1 | ANTIVIRAL CELL PENETRATING PEPTIDES | New York Blood Center (US) | 2011-02-16 | — | — | EP | claimed |
| US-20090281041-A1 | ANTIVIRAL CELL-PENETRATING PEPTIDES | NEW YORK BLOOD CENTER | 2009-11-12 | — | — | US | claimed |
| WO-2009137532-A1 | ANTIVIRAL CELL PENETRATING PEPTIDES | NEW YORK BLOOD CENTER (US) | 2009-11-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130059776-A1 | Antiviral Cell-Penetrating Peptides | ZC3HAV1, MAVS, HAVCR2 | CYP1A2 4845/4885CYP2C19 4477/4885BLM 3694/4885 |
| US-12391733-B2 | Stapled intracellular-targeting antimicrobial peptides to treat infection | VIP, SPPL2B, HM13 | CYP1A2 4876/4885CYP2C19 4707/4885BLM 3040/4885 |
| US-20090281041-A1 | ANTIVIRAL CELL-PENETRATING PEPTIDES | ZC3HAV1, MAVS, HAVCR2 | CYP1A2 4845/4885CYP2C19 4477/4885BLM 3694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.